Robert Goulart to Middle Aged
This is a "connection" page, showing publications Robert Goulart has written about Middle Aged.
Connection Strength
0.226
-
Pantanowitz L, Freeman J, Goulart RA. Utility of cell block preparations in cytologic specimens diagnostic of lymphoma. Acta Cytol. 2010 Mar-Apr; 54(2):236-7.
Score: 0.027
-
Pantanowitz L, Hornish M, Cao QJ, Goulart RA. HPV data can be used as a cytopathology laboratory quality indicator. Diagn Cytopathol. 2010 Feb; 38(2):159-60.
Score: 0.026
-
Pantanowitz L, Otis CN, Goulart RA. Cytologic findings of psammocarcinoma in peritoneal washings. Acta Cytol. 2009 May-Jun; 53(3):263-7.
Score: 0.025
-
Pantanowitz L, Warren M, Goulart RA. Anthracotic pigment in pleural fluid: a case report. Acta Cytol. 2009 May-Jun; 53(3):306-8.
Score: 0.025
-
Pantanowitz L, Galan A, Gang DL, Crisi GM, LaPolice P, Goulart RA. Diagnostic cytologic features of an epididymal melanotic neuroectodermal tumor of infancy present in scrotal fluid: a case report. Acta Cytol. 2006 Jul-Aug; 50(4):460-5.
Score: 0.021
-
Crisi GM, Marconi SA, Makari-Judson G, Goulart RA. Expression of c-kit in adenoid cystic carcinoma of the breast. Am J Clin Pathol. 2005 Nov; 124(5):733-9.
Score: 0.020
-
Nayar R, Chhieng DC, Crothers B, Darragh TM, Davey DD, Eisenhut C, Goulart R, Huang EC, Tabbara SO. Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories. J Am Soc Cytopathol. 2020 Jul - Aug; 9(4):291-303.
Score: 0.013
-
Goulart RA, Mark EJ, Rosen S. Tumefactions as an extravascular manifestation of Wegener's granulomatosis. Am J Surg Pathol. 1995 Feb; 19(2):145-53.
Score: 0.009
-
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol. 2015 Feb; 136(2):178-82.
Score: 0.009
-
Nayar R, Goulart RA, Tiscornia-Wasserman PG, Davey DD. Primary human papillomavirus screening for cervical cancer in the United States-US Food and Drug Administration approval, clinical trials, and where we are today. Cancer Cytopathol. 2014 Oct; 122(10):720-9.
Score: 0.009
-
Davis Davey D, Davey DD, Goulart R, Nayar R. 2013 statement on human papillomavirus test utilization [corrected]. Diagn Cytopathol. 2014 May; 42(5):449-52.
Score: 0.009
-
Davey DD, Goulart R, Nayar R. 2013 statement on human papillomavirus DNA test utilization. Am J Clin Pathol. 2014 Apr; 141(4):459-61.
Score: 0.009
-
Davis Davey D, Goulart R, Nayar R. 2013 statement on human papillomavirus [corrected] test utilization. Cancer Cytopathol. 2014 Feb; 122(2):83-6.
Score: 0.009
-
Kandil D, Leiman G, Allegretta M, Trotman W, Pantanowitz L, Goulart R, Evans M. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions. Cancer. 2007 Oct 25; 111(5):316-22.
Score: 0.006
-
Modem RR, Florence RR, Goulart RA, Pantanowitz L. Pulmonary Aspergillus-associated calcium oxalate crystals. Diagn Cytopathol. 2006 Oct; 34(10):692-3.
Score: 0.005
-
Pantanowitz L, Florence RR, Goulart RA, Otis CN. Trichomonas vaginalis P16 Immunoreactivity in cervicovaginal Pap tests: a diagnostic pitfall. Diagn Cytopathol. 2005 Sep; 33(3):210-3.
Score: 0.005